Research literacy · Issue 01 · 11 October 2026

Peptide research: what a study can actually tell you

The useful question is not whether a peptide has a compelling headline. It is whether the evidence answers the question you care about.

Start with the original study

A social post is a starting point, not the evidence. Open the original paper. Look for the study design, the people enrolled, the comparison group and the length of follow-up.

Two widely discussed randomized trials in the New England Journal of Medicine studied adults with overweight or obesity who did not have diabetes. One followed participants for 68 weeks; the other for 72 weeks. Those details define the studies. They do not describe every patient or every product being discussed online.

Read beyond the headline

  1. Who was studied? Check inclusion and exclusion criteria. A finding in one group is not a promise for another.
  2. What was the comparison? A trial with a control group answers a different question from an uncontrolled report.
  3. What was measured? Distinguish the main outcome from exploratory findings. Read the limitations and safety reporting.
  4. What exact preparation was tested? Do not treat evidence for one studied medicine as evidence for every compounded or research-use product.

Keep research and access separate

FDA says unapproved versions of GLP-1 drugs do not undergo its review for safety, effectiveness and quality before marketing. A study link is not proof that an offered product is approved or appropriate for a particular person.

FDA: concerns with unapproved GLP-1 drugs

Educational editorial content. Crestpath provides business price comparisons, not healthcare products or medical advice.